Latest filing published 15 May 2026 for CVS HEALTH Corp, €171k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey R. Balser, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CVS HEALTH Corp and Varian Medical Systems Inc. The record holds 13 filings, for trades running from 15 November 2019 to 14 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 15 May 2026, the filings show a share grant worth €171k in CVS HEALTH Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations